The
report on global cell-based assays market provides qualitative and quantitative
analysis for the period of 2017 to 2023. According to report the global
cell-based assays market is expected to grow at a CAGR between 8.0% and 8.5 %
over the forecast period of 2017 - 2023. The global market size was USD 11.3
billion in 2015.
Figure 1: Global Cell-based Assays Market by Value 2015 - 2023
Market
Insights:
The
report identified that global cell-based assays is driven by factors such as
growing drug discovery activity, increasing incidence of chronic diseases, and
growing preference for cell-based assays. While the restraining factors include
high cost of cell-based assays deployment and instruments. Further, the report
identifies the opportunities in the world market as emerging markets in Asian countries.
Segments
Covered
The
report on global cell-based assays market covers the segments based on
products and services, applications, and end user. The products and
services of cell-based assays include instruments, consumables,
software and services. The applications segment includes drug discovery, basic
research, predictive toxicology, ADME studies and other applications. On
the basis of end user pharmaceutical & biotechnology companies, contract
research organizations, academic & government institutions and other end
users.
Geographies
covered
The
report provides regional analysis covering geographies such as North America,
Europe, Asia-Pacific, and Rest of the World. In this section the key trends and
market size for each geography are provided over the period of 2017 – 2023.
Figure 2: Global Cell-based Assays Market by Region
Globally, North
America market dominated the world cell-based assays market followed by
Europe and Asia-Pacific. Furthermore, Asia Pacific market is
expected to grow at the highest CAGR over the forecast period 2017-2023.Due to
the increasing growth of cell based assays market in China, Japan, and
India
Companies
Profiled:
The
report provides profiles of the companies in the global cell-based assays market
such as, Perkinelmer, Inc., Thermo Fisher Scientific Inc., Becton, Dickinson
and Company, General Electric Company, Merck KGaA, Danaher Corporation, Charles
River Laboratories, Inc., Cisbio Bioassays, Promega Corporation, and Cell
Biolabs Inc.
Report
Highlights:
The
report provides deep insights on demand forecasts, market trends and micro and
macro indicators. In addition, this report provides insights on the factors
that are driving and restraining the global cell-based assays market. Moreover,
IGR-Growth Matrix analysis given in the report brings an insight on the
investment areas that existing or new market players can consider.
The
report provides insights into the market using analytical tools such as
Porter’s five forces analysis and DRO analysis of cell-based assays market.
Moreover, the study highlights current market trends and provides forecast from
2017 to 2023. We also have highlighted future trends in the cell-based assays market
that will impact the demand during the forecast period. Moreover, the
competitive analysis given in each regional market brings an insight on the
market share of the leading players. Additionally, the analysis highlights rise
and fall in the market shares of the key players in the market.
This report will help manufacturers, suppliers
and distributors of the cell-based
assays market to understand the present and
future trends in this market and formulate their strategies accordingly.
Please Choose One of them.